Sign in to view content

Predicting Long-term Response to Ranibizumab After Three Injections in Patients With Age-Related Macular Degeneration

Paul Hahn, MD, PhD, FASRS

Video
Published 2020

Related

Longitudinal Total Retinal Fluid Index Assessment in nAMD From the OSPREY Study: A Novel Assessment of Fluid Drying Effect
Sunil Srivastava, MD
On Demand Cases, Courses, and Papers
2020
Subretinal Delivery of RGX-314 for Neovascular AMD: End of Study Phase I/IIa Results
Lejla Vajzovic, MD, FASRS
Annual Meeting Talks
2021
Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial
Peter A. Campochiaro, MD
Updates from the Field
2021

Category: AMD-Neovascular

See more